ALKS · Alkermes plc
United States · RS rating 79 · As of 2026-11-03
| Price | 45.69 USD |
|---|---|
| 1-day change | +1.8% |
| RS rating (overall / 1M / 3M / 12M) | 79 / 76 / 50 / 85 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 40 / 46 / 16 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -40.8% |
| Sales growth Q/Q | -2.5% |
| Distance from 52-week high | +17.3% |
| Market cap (USD) | $5.7B |